309 related articles for article (PubMed ID: 28030846)
1. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Jeong S; Tong Y; Sha M; Gu J; Xia Q
Oncotarget; 2017 Mar; 8(10):17292-17300. PubMed ID: 28030846
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.
Zhou HB; Wang H; Li YQ; Li SX; Wang H; Zhou DX; Tu QQ; Wang Q; Zou SS; Wu MC; Hu HP
World J Gastroenterol; 2011 Mar; 17(10):1292-303. PubMed ID: 21455328
[TBL] [Abstract][Full Text] [Related]
3. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.
Wang C; Jing H; Sha D; Wang W; Chen J; Cui Y; Han J
BMC Infect Dis; 2016 Jun; 16():295. PubMed ID: 27301956
[TBL] [Abstract][Full Text] [Related]
4. [The research progress in clinicopathological characteristics and treatment of hepatitis B virus-associated intrahepatic cholangiocarcinoma].
Tang ZH; Tong HJ; Quan ZW
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):280-283. PubMed ID: 32241057
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma.
Matsumoto K; Onoyama T; Kawata S; Takeda Y; Harada K; Ikebuchi Y; Ueki M; Miura N; Yashima K; Koda M; Sakamoto T; Endo M; Horie Y; Murawaki Y
Intern Med; 2014; 53(7):651-4. PubMed ID: 24694471
[TBL] [Abstract][Full Text] [Related]
6. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma.
Seo JW; Kwan BS; Cheon YK; Lee TY; Shim CS; Kwon SY; Choe WH; Yoo BC; Yoon JM; Lee JH
Korean J Intern Med; 2020 May; 35(3):566-573. PubMed ID: 31916422
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection and intrahepatic cholangiocarcinoma.
Zhou HB; Hu JY; Hu HP
World J Gastroenterol; 2014 May; 20(19):5721-9. PubMed ID: 24914333
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.
Lee CH; Hsieh SY; Chang CJ; Lin YJ
J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166
[TBL] [Abstract][Full Text] [Related]
10. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma.
Zhang L; Cai JQ; Zhao JJ; Bi XY; Tan XG; Yan T; Li C; Zhao P
J Surg Oncol; 2010 Mar; 101(3):233-8. PubMed ID: 20169539
[TBL] [Abstract][Full Text] [Related]
11. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
12. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.
Wang Z; Sheng YY; Dong QZ; Qin LX
World J Gastroenterol; 2016 Mar; 22(10):3038-51. PubMed ID: 26973400
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma.
Tao LY; He XD; Xiu DR
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):682-687. PubMed ID: 27282820
[TBL] [Abstract][Full Text] [Related]
16. Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis.
Jeong S; Luo G; Wang ZH; Sha M; Chen L; Xia Q
Hepatol Int; 2018 Jul; 12(4):330-338. PubMed ID: 29947010
[TBL] [Abstract][Full Text] [Related]
17. Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma.
Shi Y; Jiang Z; Yang Y; Zheng P; Wei H; Lin Y; Lv G; Yang Q
Parasitol Res; 2017 Oct; 116(10):2645-2649. PubMed ID: 28801696
[TBL] [Abstract][Full Text] [Related]
18. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L
J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.
Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S
Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186
[TBL] [Abstract][Full Text] [Related]
20. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
